International Journal of Clinical Research

Objective To explore the effect of transurethral plasma resection of prostate in the treatment of benign prostatic hyperplasia. Methods: 80 patients with benign prostatic hyperplasia admitted to the hospital from December 2021 to December 2022 were selected for study. They were equally divided into the observation group and the control group. 40 patients with holmium laser enucleation of the prostate were treated as the control group, and the remaining patients were treated with transurethral plasma resection of the prostate as the observation group. Results: Intraoperative bleeding volume, bladder flushing time and other clinical indicators between groups; There was no significant difference in IPSS, QOL, PVR and Qmax between the two groups before operation (P>0.05). Compared with that before operation, all indexes of the two groups were significantly improved three months after operation. Conclusion: Transurethral plasma resection of prostate and holmium laser enucleation of prostate are effective methods for the treatment of benign prostatic hyperplasia, which can effectively improve the clinical symptoms of patients.

Transurethral plasma resection of prostate; Holmium laser enucleation of prostate; Benign prostatic hyperplasia; Clinical effect